Moderna will pay US$950-million upfront in July, 2026, with an additional US$1.3-billion contingent on the outcome of a separate legal appeal, while not owing royalties for the technology in its ...

Moderna shares rose 10% in premarket trading on Wednesday after the company settled a long-running legal battle over the technology that made its COVID-19 vaccine possible, ...

Moderna will pay $950 million upfront in July 2026, with an additional $1.3 billion contingent on the outcome of a separate ...

The Cambridge-based drug maker said the deal settles "all worldwide" litigation related to certain drugs and it won't have to pay royalties to other companies.

Researchers at University California San Diego School of Medicine have found that a natural fungal supplement taken at the ...

How people with compromised immune systems respond to vaccines is an important area of immunological research. A new study led by York University found that not only could machine-learning models ...

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock added almost 9% after it was announced that the drugmaker has agreed to pay up to $2.25 billion to settle a global patent infringement lawsuit brought by ...

Donald Sturgeon has said that he had followed his "moral conscience" according to his Roman Catholic beliefs in refusing the ...

Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...

CDC data show SARS-CoV-2 and RSV continue to impact younger children and older adults, with significant hospitalization and mortality rates across the US.

The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency. The researcher asking for the ...

The United States and Israel have launched coordinated military strikes across Iran for a fifth consecutive day, targeting Tehran and other major cities.